I think the key question for CHS, or even Amesh specifically, is whether they outperformed other organizations, and by how much—i.e. were investments in CHS positive contributions to response overall. And they / he could have done almost arbitrarily bad in February, and still overall have vastly outperformed the alternatives.
And I think that it’s clear that CHS’s work was impactful in increasing preparedness in the US, even if the level of preparedness was far short of what was needed.
(Note that I have personal biases about this, and know many of the people at CHS.)
I think the key question for CHS, or even Amesh specifically, is whether they outperformed other organizations, and by how much—i.e. were investments in CHS positive contributions to response overall. And they / he could have done almost arbitrarily bad in February, and still overall have vastly outperformed the alternatives.
And I think that it’s clear that CHS’s work was impactful in increasing preparedness in the US, even if the level of preparedness was far short of what was needed.
(Note that I have personal biases about this, and know many of the people at CHS.)